Dr. Lisa Higgins is a Senior Research Fellow and Lead of the Health Economics Program at the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) at Monash University, Australia. She is an NHMRC Emerging Leader Fellow whose research focuses on the long-term outcomes of critically ill patients, evaluating the costs of care in critical illness and conducting economic evaluations alongside clinical trials in critical care. In 2020 and 2021, Lisa led the data coordination team and currently lead the health economics program for the REMAP-CAP trial, an international Bayesian platform trial being conducted in >300 sites in >20 countries, which has provided crucial evidence to inform national and international guidelines for the management of COVID-19 in critically ill patients. Lisa has authored over 90 publications (including in the New England Journal of Medicine and JAMA) and has received over $50 million in competitive grant funding. Lisa is a member of the Australasian Clinical Trials Alliance’s (ACTA) Health Economics alongside Trials (HEAT) group and was a key member of ACTA’s Research Prioritisation Reference Group. She also serves on the Victorian ECMO Service’s Strategic Research Working Group, the ANZICS CORE Patient Reported Outcomes and Experience Measures Working Party and is on the editorial board for Australian Critical Care.